参考文献/References:
[1] Lindroos M,Kupari M,Heikkil? J,et al. Prevalence of aortic valve abnormalities in the elderly:an echocardiographic study of a random population sample[J]. J Am Coll Cardiol,1993,21(5):12205.
[2] Nkomo VT,Gardin JM,Skelton TN,et al. Burden of valvular heart diseases:a population-based study[J]. Lancet,2006,368(9540):1005-1011.
[3] Iung B,Cachier A,Baron G,et al. Decision-making in elderly patients with severe aortic stenosis:why are so many denied surgery?[J]. Eur Heart J,2005,26(24): 2714-2720.
[4] Cribier A,Eltchaninoff H,Bash A,et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis[J].Circulation,2002,106(24):3006-3008.
[5] 潘文志,周达新,葛均波.经导管主动脉瓣置换术的中国现状2017[J].华西医学,2018,33(2):140-144.
[6] Nishimura RA,Otto CM,Bonow RO,et al,2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation,2017,135(25):e1159-e1195.
[7] Vahanian A,Alfieri O,Andreotti F, et al. Guidelines on the management of valvular heart disease(version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology(ESC) and the European Association for Cardio-Thoracic Surgery(EACTS) [J]. G Ital Cardiol (Rome),2013,14(3):167-214.
[8] 葛均波,周达新,潘文志,等. 经皮主动脉瓣植入术一例及其操作要点[J]. 中国介入心脏病学杂志,2010,18(5):243-246.
[9] Stefanini GG,Stortecky S,Meier B,et al. Severe aortic stenosis and coronary artery disease[J]. EuroIntervention,2013,9(5):S63-S68.
[10] Exadactylos N,Sugrue DD,Oakley CM. Prevalence of coronary artery disease in patients with isolated aortic valve stenosis[J]. Br Heart J,1984,52(6):688-689.
[11] Ortlepp JR,Schmitz F,Bozoglu T,et al. Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study[J]. Heart,2003,89(9):1019-1022.
[12] Gilard M,Eltchaninoff H,Iung B,et al. Registry of transcatheter aortic-valve implantation in high-risk patients[J]. N Engl J Med,2012,366(18):1705-1715.
[13] Moat NE,Ludman P,de Belder MA,et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis:the U.K. TAVI(United Kingdom Transcatheter Aortic Valve Implantation) Registry[J]. J Am Coll Cardiol,2011,58(20):2130-2138.
[14] Dewey TM,Brown DL,Herbert MA,et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation[J]. Ann Thorac Surg,2010,89(3):758-767.
[15] Sankaramangalam K,Banerjee K,Kandregula K,et al. Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis[J]. J Am Heart Assoc,2017,6(10):e006092.
[16] Mancio J,Fontes-Carvalho R,Oliveira M,et al. Coronary artery disease and symptomatic severe aortic valve stenosis: clinical outcomes after transcatheter aortic valve implantation[J]. Front Cardiovasc Med,2015,15(2):18.
[17] Puymirat E, Didier R, Eltchaninoff H, et al. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement:insights from the FRANCE-2 registry[J]. Clin Cardiol,2017,40(12):1316-1322.
[18] Goel SS,Ige M,Tuzcu EM,et al. Severe aortic stenosis and coronary artery disease—implications for management in the transcatheter aortic valve replacement era: a comprehensive review[J]. J Am Coll Cardiol,2013,62(1):1-10.
[19] Wenaweser P,Pilgrim T,Guerios E,et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation[J]. EuroIntervention,2011,7(5):541-548.
[20] Voudris KV,Petropulos P,Karyofillis P,et al. Timing and outcomes of PCI in the TAVR Era[J]. Curr Treat Options Cardiovasc Med,2018,20(3):22.
[21] Fowkes FG,Rudan D,Rudan I,et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010:a systematic review and analysis[J]. Lancet,2013,382(9901):1329-1340.
[22] Eveborn GW,Schirmer H,Heggelund G,et al. The evolving epidemiology of valvular aortic stenosis. The Troms? study[J]. Heart,2013,99(6):396-400.
[23] Leon MB,Smith CR,Mack M,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery[J]. N Engl J Med, 2010,363(17):1597-1607.
[24] Kaul S. Transcatheter aortic-valve replacement with a self-expanding prosthesis[J]. N Engl J Med,2014,371(10):1790-1798.
[25] Yotti R,Bermejo J,Gutiérrez-Iba?es E,et al. Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement[J]. J Am Coll Cardiol,2015,65(5):423-433.
[26] Martinez-Selles M,Barrio JM,Hortal J,et al.Prevalence of peripheral arterial disease and prior stroke in octogenarians with symptomatic severe aortic stenosis or severe coronary artery disease:influence in management and outcome[J]. Int Angiol, 2007,26(1):33-37.
[27] Fanaroff AC,Manandhar P,Holmes DR,et al. Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry[J]. Circ Cardiovasc Interv,2017,10(10): e005456.
[28] Ando T,Adegbala O,Akintoye E,et al. Is transcatheter aortic valve replacement better than surgical aortic valve replacement in patients with chronic obstructive pulmonary disease? A nationwide inpatient sample analysis[J].J Am Heart Assoc,2018,7(7):e008408.
[29] Mok M,Nombela-Franco L,Dumont E,et al. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation:insights on clinical outcomes,prognostic markers,and functional status changes[J]. JACC Cardiovasc Interv,2013,6(10):1072-1084.
[30] Crestanello JA,Popma JJ,Adams DH,et al. Long-term health benefit of TAVR in patients with chronic lung disease[J]. JACC Cardiovasc Interv,2017,10(22):2283-2293.
[31] Halkos ME,Kilgo P,Lattouf OM,et al. The effect of diabetes mellitus on in-hospital and long-term outcomes after heart valve operations[J]. Ann Thorac Surg,2010,90(1):124-130.
[32] Ando T,Akintoye E,Telila T,et al. Comparison of hospital outcome of transcatheter versus surgical aortic valve replacement in patients with diabetes mellitus(from the nationwide inpatient sample)[J]. Am J Cardiol,2017,119(8):1250-1254.
[33] Abramowitz Y,Vemulapalli S,Chakravarty T,et al.Clinical impact of diabetes mellitus on outcomes after transcatheter aortic valve replacement insights from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry[J]. Circ Cardiovasc Interv,2017,10(11):e005417.
[34] Berkovitch A,Segev A,Barbash I,et al. Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement[J]. Cardiovasc Diabetol,2015,10(14):131.
[35] Mina GS,Gill P,Soliman D,et al. Diabetes mellitus is associated with increased acute kidney injury and 1-year mortality after transcatheter aortic valve replacement: a meta-analysis[J]. Clin Cardiol,2017,40(9):726-731.
[36] Masuda C,Dohi K,Sakurai Y,et al. Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease[J]. Cardiovasc Ultrasound,2011,16(9):31.
[37] Duncan A,Ludman P,Banya W,et al. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis:the U.K. Transcatheter Aortic Valve Implantation Registry[J]. JACC Cardiovasc Interv,2015, 8(5):645-653.
[38] Gupta T,Goel K,Kolte D,et al. Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv,2017,10(20):2050-2060.
[39] Thourani VH,Forcillo J,Beohar N,et al. Impact of preoperative chronic kidney disease in 2,531 high-risk and inoperable patients undergoing transcatheter aortic valve replacement in the PARTNER trial[J].Ann Thorac Surg,2016,102(4):1172-1180.
[40] Makki N,Lilly SM. Advanced chronic kidney disease:relationship to outcomes post-TAVR, a meta-analysis[J]. Clin Cardiol,2018,41(8):1091-1096.
[41] Tjahjadi C,Wee Y,Hay K,et al. Heyde syndrome revisited:anaemia and aortic stenosis[J]. Intern Med J,2017,47(7):814-818.
[42] D’Errigo P,Biancari F,Rosato S,et al. Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia[J]. Acta Cardiol,2018,73(1):50-59.
[43] Kanjanahattakij N,Rattanawong P,Krishnamoorthy P,et al. Anaemia and mortality in patients with transcatheter aortic valve replacement:a systematic review and meta-analysis[J]. Acta Cardiol,2018,10(17):1-7.
[44] DeLarochellière H,Urena M,Amat-Santos IJ,et al. Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement[J]. Am J Cardiol,2015,115(4):472-479.
相似文献/References:
[1]于海波,综述,梁延春,等.经导管主动脉瓣膜置换术后房室传导阻滞的预警[J].心血管病学进展,2016,(4):419.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
YU Haibo,LIANG Yanchun.Predicting Factors of Atrioventricular Block after Transcatheter
Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2016,(5):419.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
[2]谢晓川,饶莉.经导管主动脉瓣植入术临床研究进展[J].心血管病学进展,2015,(6):700.[doi:10.3969/j.issn.1004-3934.2015.06.011]
XIE Xiaochuan,RAO Li.Clinical Research Progress in Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2015,(5):700.[doi:10.3969/j.issn.1004-3934.2015.06.011]
[3]刘新民 宋光远 吴永健.左心室导丝起搏技术在经导管主动脉瓣置换术中的应用[J].心血管病学进展,2021,(4):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
LIU Xinmin,SONG Guangyuan,WU Yongjian.Application of Left Ventricular Guidewire Pacing in Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2021,(5):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
[4]夏平.“8+2”心电图临床价值的研究进展夏平[J].心血管病学进展,2021,(9):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
XIA Ping.Clinical Value of 8 Plus 2 ECG[J].Advances in Cardiovascular Diseases,2021,(5):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
[5]陈阳 赵庆豪 赵杰 吴永健.经导管主动脉瓣置换术时代慢性主动脉瓣反流诊治进展[J].心血管病学进展,2022,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
CHEN Yang,ZHAO Qinghao,SONG Guangyuan,et al.Diagnosis and Treatment of Chronic Aortic Regurgitation in Transcatheter Aortic Valve Replacement Era[J].Advances in Cardiovascular Diseases,2022,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
[6]董一娜 雷芳芳 宋启煦 王晶 杨艳.经导管主动脉瓣置换术后死亡风险预测模型系统评价[J].心血管病学进展,2022,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
DONG Yina,LEI Fangfang,SONG Qixu,et al.Mortality Risk Prediction Models After Transcatheter?span>Aortic Valve Replacement:A Systematic Review[J].Advances in Cardiovascular Diseases,2022,(5):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
[7]张木馨 李丽英 阮海燕 何森.经导管主动脉瓣置换术后抗栓治疗进展[J].心血管病学进展,2022,(6):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
ZHANG Muxin,LI Liying,RUAN Haiyan,et al.Progress of Antithrombotic Therapy after?ranscatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(5):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
[8]. 经导管主动脉瓣置换术术后抗栓治疗的研究进展 [J].心血管病学进展,2022,(7):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
DUAN ZhenyaWU Yongjian.Antithrombotic Therapy After Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2022,(5):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[9]胡正 陈祥 洲陈静.经导管主动脉瓣置换术后冠状动脉阻塞的研究进展[J].心血管病学进展,2023,(5):402.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.005]
HUZheng,CHENXiangzhou,CHENJing.Coronary Occlusion of Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2023,(5):402.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.005]
[10]邵美华 周玉强 王萌萌 王宝珠 马翔.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄研究进展[J].心血管病学进展,2020,(11):1184.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[11]李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄.经导管主动脉瓣置换术后合并心房颤动的抗栓策略[J].心血管病学进展,2021,(10):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
LI ZongzeHE GuijunZHENG XiaofeiJIANG HuiLIU Hanxiong.Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(5):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
[12]王卫卫 于子凯 吴永健 许海燕 刘庆荣.序贯综合心脏康复模式在经导管主动脉瓣置换术患者中应用现状[J].心血管病学进展,2022,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
WANG Weiwei,YU Zikai,WU YongjianXU HaiyanLIU Qingrong.The Status of Sequential Comprehensive Cardiac Rehabilitation in Patients?ndergoing Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(5):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
[13]张航 安景辉 石凤梧.极简式经导管主动脉瓣置换术的研究现状[J].心血管病学进展,2022,(9):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
ZHANG Hang,AN Jinghui,SHI Fengwu.Minimalist Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(5):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
[14]达尼亚尔·迪力木拉提 施林 严飞.二叶式主动脉瓣发病机制及其临床诊治的研究进展[J].心血管病学进展,2023,(5):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]
Daniyar·Dilmurat,SHI Lin,YAN Fei.The PathogenesisClinical Diagnosis and Treatment of Bicuspid Aortic Valve[J].Advances in Cardiovascular Diseases,2023,(5):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]